Armstrong Pharma Acquired by Medeva
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
TM Capital and its Swiss M&A International Inc. partner, Binder Corporate Finance, advised Datamars SA in the sale of a majority ownership stake of the Company to a group of private equity investors
TM Capital advised Hitachi Consulting, a subsidiary of Hitachi Ltd. (NYSE), in its acquisition of Edenbrook Ltd., a UK-based IT consulting firm
TM Capital, together with our Oaklins partner Audon of Denmark, advised Bloomingville A/S in its sale to Creative Co-Op Inc.
TM Capital represented Micromeritics Instrument Corporation in connection with the acquisition of Process Integral Development S.L.
TM Capital completed the sale by Heywood Williams Group PLC (LSE) of its J&B Products Division to Federal Process Corporation
TM Capital advised ProActivity, Ltd. in its sale to EMC Corporation (NYSE), a world leader in Information Lifecycle Management solutions
TM Capital served as financial advisor to LaSalle Bristol, a distributor of products to the manufactured housing and recreational vehicle markets, in arranging a Revolving Credit facility to fund working capital
TM Capital served as exclusive financial advisor to Nomura Research Institute (TYO: 4307) in its acquisition of Brierley+Partners
TM Capital represented Micromeritics Instrument Corporation in connection with the acquisition of Freeman Technologies Ltd.